These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12241827)

  • 21. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].
    Tebbe U; Bramlage P; von Löwis of Menar P; Lawall H; Gaudron P; Lüders S; Klaus A; Lengfelder W; Scholz KH; Maziejewski S; Cuneo A; Hohmann V; Gulba D
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2000-5. PubMed ID: 17882737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction.
    Jeon C; Candia SC; Wang JC; Holper EM; Ammerer M; Kuntz RE; Mauri L
    Am Heart J; 2010 Jul; 160(1):195-201. PubMed ID: 20598992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
    Han JH; Chandra A; Mulgund J; Roe MT; Peterson ED; Szczech LA; Patel U; Ohman EM; Lindsell CJ; Gibler WB
    Am J Med; 2006 Mar; 119(3):248-54. PubMed ID: 16490471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of acute coronary syndromes in cardiology departments of the Emilia Romagna region: the AI-CARE2 study].
    Pavesi PC; Ottani F; Bologna F; Gaddi O; Alboni P; Galvani M
    Ital Heart J Suppl; 2003 Sep; 4(9):733-44. PubMed ID: 14635391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electrocardiographic ST-segment deviation in acute inferoposterior myocardial infarction caused by obstruction of the left circumflex coronary artery].
    Fujiwara M; Horimoto M; Shiokoshi T; Takenaka T; Igarashi K
    J Cardiol; 1993; 23(3):249-56. PubMed ID: 8046589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.
    Fox KA; Poole-Wilson P; Clayton TC; Henderson RA; Shaw TR; Wheatley DJ; Knight R; Pocock SJ
    Lancet; 2005 Sep 10-16; 366(9489):914-20. PubMed ID: 16154018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is early invasive treatment in acute coronary syndromes necessary? Suggestions to alternative interpretation of the FRISC II study].
    Möller BH
    Lakartidningen; 2002 Aug; 99(32-33):3219-24. PubMed ID: 12219478
    [No Abstract]   [Full Text] [Related]  

  • 32. Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction.
    Lawesson SS; Stenestrand U; Lagerqvist B; Wallentin L; Swahn E
    Heart; 2010 Mar; 96(6):453-9. PubMed ID: 20299414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of evolving myocardial infarction by intracoronary thrombolysis and subsequent aorta-coronary bypass.
    Krebber HJ; Mathey D; Kuck KJ; Kalmar P; Rodewald G
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):186-93. PubMed ID: 6977071
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute myocardial infarction caused by simultaneous occlusion of the right coronary artery and the left anterior descending coronary artery probably due to coronary spasm: a case report.
    Suzuki N; Hiasa Y; Miyazaki S; Tomokane T; Ogura R; Miyajima H; Ohara Y; Yuba K; Takahashi T; Hosokawa S; Kishi K; Ohtani R
    J Cardiol; 2005 May; 45(5):213-7. PubMed ID: 15929389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease.
    Farzaneh-Far A; Borges-Neto S
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):746-53. PubMed ID: 22086945
    [No Abstract]   [Full Text] [Related]  

  • 40. Invasive versus noninvasive management of ST-elevation acute myocardial infarction: a review of clinical trials and observational studies.
    Beck CA; Eisenberg MJ; Pilote L
    Am Heart J; 2005 Feb; 149(2):194-9. PubMed ID: 15846255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.